Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases

Annals of the Rheumatic Diseases

Volumn 69, Issue 12, 2010, Pages 2204-2212

  Amin, M Asif ^a   Rabquer, Bradley J ^a   Mansfield, Pamela J ^a   Ruth, Jeffrey H ^a   Marotte, Hubert ^a   Haas, Christian S ^a   Reamer, Elyse N ^a   Koch, Alisa E ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Veteran's Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 18; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HOMING; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ARTHRITIS, RHEUMATOID; CHEMOTAXIS; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; INTERLEUKIN-18; LAMININ; MAP KINASE KINASE 4; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTEOGLYCANS; SKIN; SRC-FAMILY KINASES; SYNOVIAL MEMBRANE;

EID: 78649742262     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.127241     Document Type: Article

References (37)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Szekanecz Z, Koch AE, Kunkel SL, et al. Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging 1998;12:377-90. (Pubitemid 28220849)
3. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
4. Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001;167:1644-53.
5. Amin MA, Mansfield PJ, Pakozdi A, et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum 2007;56:1787-97.
6. Morel JC, Park CC, Kumar P, et al. Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest 2001;81:1371-83.
7. Yoo JK, Kwon H, Khil LY, et al. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol 2005;175:8280-6.
8. Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103(1 Pt 1):11-24.
9. Dai SM, Matsuno H, Nakamura H, et al. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 2004;50:432-43.
10. Gracie JA, Forsey RJ, Chan WL, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
11. Joosten LA, van De Loo FA, Lubberts E, et al. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000;165:6553-8.
12. Smeets RL, van de Loo FA, Arntz OJ, et al. Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther 2003;10:1004-11.
13. Amin MA, Volpert OV, Woods JM, et al. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 2003;93:321-9.
14. Kumar P, Amin MA, Harlow LA, et al. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 2003;101:3960-8.
15. Eliceiri BP, Paul R, Schwartzberg PL, et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999;4:915-24.
16. Pedram A, Razandi M, Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 2001;142:1578-86. (Pubitemid 32299687)
17. Uchida C, Gee E, Ispanovic E, et al. JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 2008;32:769-76.
18. Kito H, Chen EL, Wang X, et al. Role of mitogen-activated protein kinases in pulmonary endothelial cells exposed to cyclic strain. J Appl Physiol 2000;89:2391-400.
19. Amin MA, Haas CS, Zhu K, et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 2006;107:2252-61.
20. Amin MA, Ruth JH, Haas CS, et al. H-2g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum 2008;58:689-95.
21. Ruth JH, Haas CS, Park CC, et al. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006;54:765-78.
22. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
23. Szekanecz Z, Gáspár L, Koch AE. Angiogenesis in rheumatoid arthritis. Front Biosci 2005;10:1739-53.
24. Qiao H, Sonoda KH, Ikeda Y, et al. Interleukin-18 regulates pathological intraocular neovascularization. J Leukoc Biol 2007;81:1012-21.
25. Cho ML, Jung YO, Moon YM, et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 2006;103:159-66.
26. Kim J, Shao Y, Kim SY, et al. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway. Mol Biol Cell 2008;19:433-44.
27. Carrascal MT, Mendoza L, Valcárcel M, et al. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res 2003;63:491-7.
28. Cao R, Farnebo J, Kurimoto M, et al. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J 1999;13:2195-202.
29. Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, et al. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ Res 2002;91:441-8.
30. Kim KE, Song H, Kim TS, et al. Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 2007;26:1468-76.
31. Pedram A, Razandi M, Levin ER. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 1998;273:26722-8.
32. Pollet I, Opina CJ, Zimmerman C, et al. Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. Blood 2003;102:1740-2.
33. Matsuno H, Yudoh K, Uzuki M, et al. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. J Rheumatol 2002;29:890-5.
34. Nagashima M, Tanaka H, Takahashi H, et al. Study of the mechanism involved in angiogenesis and synovial cell proliferation in human synovial tissues of patients with rheumatoid arthritis using SCID mice. Lab Invest 2002;82:981-8.
35. Ergün S, Hohn HP, Kilic N, et al. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells. Stem Cell Rev 2008;4:169-77.
36. Bertolini F, Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006;6:835-45.
37. Shaked Y, Bertolini F, Man S, et al. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis;Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005;7:101-11.